Icosagen is a unique European CRDMO, being successfully in the business for more than 25 years as an independent family-owned company. As such, we combine pre-clinical CRO and clinical CDMO development expertise at one single site for therapeutic antibodies, multispecifics, ADCs, and other complex recombinant protein drug candidates.
As a CRDMO we discover, develop, and manufacture proteins seamlessly from research concepts into pre-clinical and clinical development stages. This includes everything from small-scale transient productions to stable high producing cell lines, to manufacture clinical GMP materials in our modern 200/1000L GMP facility.
In 2024, we continued our partnership with over 100 biotech & pharma companies on 500 projects, producing more than different 2000 proteins.
Company Details
- Employees
- 149
- Founded
- 1999
- Address
- Eerika Tee 1, Tartu,estonia 61713,estonia
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://www.icosagen.com/
- Keywords
- biotech, pharma, research, CDMO, CRO, antibody discovery, transmembrane proteins, GMP manufacturing, cell line development, transient expression, cell culture, process development, bispecific antibodies, diagnostics, mammalian cells, biopharmaceutical manufacturing, protein drug substance development.
- HQ
- Tartu, Estonia
Icosagen Questions
Icosagen's website is https://www.icosagen.com/
Icosagen's LinkedIn profile is https://www.linkedin.com/company/icosagen
Icosagen has
149 employees.
View email and phone details for 149
employees at Icosagen.
Icosagen's industry is
Biotechnology Research
Icosagen's top competitors are
Solis Biodyne,
Gearbox Biosciences,
Gelatex,
Nanordica Medical,
Äio,
Tftak,
J. Molner,
Pharmapark Production,
Antegenes,
Tbd Pharmatech.
Icosagen's categories are Biotechnology Research
Icosagen's founding year is 1999
